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A randomised controlled trial on the 
effectiveness of screening and brief 
problem-solving counselling for elderly 
patients with undiagnosed psychological 
problems in primary care
Key Messages
1. Unrecognised psychological 
problems are common in elderly 
patients in primary care, and are 
associated with poor quality of 
life.
2. Opportunistic screening for 
psychological problems should 
be considered for elderly 
patients in primary care.
3. Primary care doctors could 
be effectively trained to 
provide brief problem-solving 
counselling.
4. Brief problem-solving 
counselling by a trained 
primary care doctor had a small 
short-term benefit on the quality 
of life of elderly persons, who 
were screened positive for 
psychological problems.
5. Further  s tudies on the 
effectiveness of group activities 
and other treatments for elderly 
patients screened positive for 
psychological problems are 
needed.
Hong Kong Med J 2008;14(Suppl 3):S31-5
Introduction
Psychological problems can impair quality of life and place an enormous burden 
on health services. Since 2002, the US Preventive Services Task Force has 
recommended routine screening of adults for depression in primary care. A key 
determinant of the benefit of screening is the availability of effective treatment. 
Problem-solving counselling (PSC) has been shown to be feasible and effective 
for treatment of major depression, adjustment disorders, and minor depression 
in primary care, but it has not been tested on screened-positive psychological 
problems.1-3
 The aim of this study was to determine whether screening followed by brief 
PSC provided by primary care doctors could improve health-related quality of 
life (HRQOL) and reduce the number of consultations among elderly patients in 
primary care with unrecognised psychological problems.
Methods
This study was conducted from November 2002 to October 2004. The study 
consisted of (1) a cross-sectional study to screen for unrecognised psychological 
problems in elderly patients in primary care, and (2) a longitudinal randomised 
single-blind placebo controlled trial of PSC on elderly patients screened positive 
for psychological problems.
 Consecutive patients aged older than 60 years attending two general out-
patient clinics in Hong Kong were screened using the Cantonese Hospital Anxiety 
and Depression Scale (HADS). Two hundred and ninety-nine subjects who had 
an HADS anxiety score of 3 or above or depression score of 6 or above were 
randomised to receive either three sessions of PSC or video-viewing (placebo). 
One hundred and fifty subjects, who screened negative were randomly selected 
to be the negative control group who did not receive any intervention. A total of 
six primary care doctors who were family medicine trainees provided the PSC 
after undergoing a standard training course of three 3-hour workshops conducted 
by an experienced clinical psychologist. All subjects continued to receive their 
usual medical care and were followed up by telephone 6, 12, 26, and 52 weeks 
after the initial screening by a trained interviewer (blinded to the screening result 
and group allocation).
Outcome measures and data analysis
The primary outcome was the change from baseline HRQOL (the SF-36 scores). 
Secondary outcomes included: changes from baseline HADS scores, monthly 
consultation rates, and the acceptability and evaluations of the PSC. The changes 
in the outcomes from baseline of each group was studied by a measurement epoch 
(week 6, 12, 26, 52) and tested by a two-sample t test. The longitudinal changes in 
outcomes in the PSC and video (placebo) groups were compared with each other 
and with the negative control group by a mixed effects model. Multivariate linear 
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regressions, controlling for demographics and morbidity, 
were used to assess whether the PSC had an effect on the 
outcomes. All group analyses were by intention to treat. 
Statistical analyses were performed using the SAS 9 and 
the SPSS packages. The level of significance was taken as 
0.05.
Results
A total of 1853 subjects were screened and 482 (26%) 
had a positive HADS score. The estimated prevalence 
of unrecognised psychological diseases was 23% (95% 
confidence interval, 13.1-33.8%) based on a sensitivity of 
80% and specificity of 90% found in a previous study.4 
Multivariate linear regressions found that a positive HADS 
score was associated with an increase in the total number 
of episodic western medicine and Chinese medicine 
consultations, and a highly significant reduction in the SF-
36 HRQOL scale (10-30 points out of a range of 100) and 
summary (11 points in the mental component summary and 
6 points in the physical component summary) scores.
 Screened-positive subjects (n=299, 62.0%) agreed to 
further intervention with 149 randomised to receive PSC 
Item Negative control Problem-solving counselling (PSC) Video (placebo)
Week 6 (n=137) Week 12 (n=131) Week 26 (n=127) Week 52 (n=112) Week 6 (n=114) Week 12 (n=113) Week 26 (n=114) Week 52 (n=103) Week 6 (n=117) Week 12 (n=117) Week 26 (n=119) Week 52 (n=106)
Physical functioning 2.5 (14.7)* 2.5 (14.1)* -0.2 (14.7) -0.8 (16.3) -0.3 (17.1) -1.7 (18.9) -3.5 (16.4)* -3.5 (16.7)* 0.5 (14.7) 1.0 (14.9) -0.8 (15.6) -1.9 (16.7)
Role-physical 4.6 (43.5) 2.3 (43.4)‡ 4.1 (41.2) 2.2 (45.0) 7.5 (51.1) 7.2 (45.0) -0.2 (47.0) 4.9 (43.9) 11.2 (47.3)* 16.1 (42.8)*‡ 4.8 (47.8) 5.6 (49.2)
Bodily pain 2.8 (27.9) 4.6 (24.8)* 2.8 (26.6) 0.1 (28.0) 3.6 (28.0) -0.1 (31.0)§ 0.7 (31.7) -4.1 (30.9)§ 7.1 (31.8)* 10.6 (32.5)*§ 7.5 (31.8)* 8.2 (30.5)* §
General health 4.6 (19.1)* 3.0 (18.6) 0.5 (21.0) 0.1 (20.4) 6.0 (25.7)* 5.1 (27.1)* 2.2 (26.3) 2.8 (26.7) 5.9 (26.2)* 9.0 (26.8)* 7.4 (27.6)* 4.6 (25.8)
Vitality -2.0 (20.9) -3.1 (21.2) -6.3 (22.2)* -5.5 (21.9)* 3.9 (24.7) -0.9 (27.8) -5.1 (27.8) -3.8 (26.0) 3.2 (25.0) -0.2 (24.5) -1.1 (24.8) 0.5 (23.0)
Social functioning 3.4 (20.2) 1.9 (20.5) 0.0 (24.9) -1.7 (22.8) 4.1 (33.1) 3.3 (35.6) 2.4 (30.4) -5.0 (29.4) 6.0 (30.7)* 5.9 (31.4)* 7.1 (33.0)* -0.6 (26.0)
Role-emotional -1.9 (30.7)† -3.1 (34.5) -4.5 (34.0)‡ -2.1 (31.7) 14.9 (51.5)*† 11.4 (55.9)* 2.3 (51.3) 1.3 (52.6) 4.5 (51.0) 9.9 (50.1)* 10.1 (47.1)*‡ 9.3 (46.4)*
Mental health -1.2 (13.5) -2.5 (13.8)* -5.0 (13.8)* -5.4 (14.8)* 3.1 (19.6) 0.8 (20.3) -0.9 (23.6) -1.2 (19.5) 0.0 (19.7) 0.3 (22.5) -0.3 (21.8) -1.0 (19.9)
Physical component summary 2.6 (9.6)* 2.5 (8.7)* 1.7 (9.0)* 0.8 (11.1) 0.9 (12.2) 0.3 (13.0)§ -0.6 (11.5) -0.7 (10.9) 2.8 (10.5)* 4.3 (10.7)*§ 1.8 (12.0) 1.3 (12.0)
Mental component summary -1.0 (7.2)† -1.9 (8.4)*† -2.7 (8.8)*‡ -2.8 (8.9)* 3.5 (12.7)*† 1.9 (13.2)† 0.0 (13.9) -0.6 (12.5) 1.0 (13.1) 0.5 (12.9) 1.4 (13.4)‡ 0.4 (12.0)
Table 1. Mean (SD) changes from baseline SF-36 scores by groups
* Significant change in SF-36 scores from baseline by paired t test, P<0.05
† Significant difference in score change between PSC and negative control groups by ANOVA, P<0.05
‡ Significant difference in score change between video and negative control groups by ANOVA, P<0.05
§ Significant difference in score change between PSC and video groups by ANOVA, P<0.05
Score Negative control Problem-solving counselling (PSC) Video (placebo)
Week 6 (n=137) Week 12 (n=131) Week 26 (n=127) Week 52 (n=112) Week 6 (n=114) Week 12 (n=113) Week 26 (n=114) Week 52 (n=103) Week 6 (n=117) Week 12 (n=117) Week 26 (n=119) Week 52 (n=106)
Anxiety score 0.6 (1.8)*†‡ 0.6 (1.7)*†‡  0.6 (1.8)*†‡ 0.5 (1.7)*†‡ -1.3 (3.8)*† -1.4 (4.2)*† -1.7 (4.2)*† -1.1 (4.1)*† -1.7 (3.2)*‡ -1.7 (3.2)*‡ -2.0 (3.2)*‡ -1.8 (3.5)*‡
Depression score 2.5 (4.2)*† 2.3 (3.8)*† 2.1 (3.7)*† 2.2 (3.4)* 0.5 (4.5)† 0.8 (4.7)† 0.9 (4.9)† 1.5 (4.8)* 1.0 (4.7)* 1.0 (4.7)* 1.1 (5.1)* 1.6 (4.9)*
Table 2. Mean (SD) changes in the Cantonese Hospital Anxiety and Depression Scale (HADS) scores from baseline by groups
* Significant change in HADS scores from baseline within the same group by parried t tests; P<0.05
† Significant difference in change in HADS score between PSC and negative control groups by ANOVA; P<0.05
‡ Significant difference in change in HADS score between video and negative control groups by ANOVA; P<0.05
Item Problem-solving counselling vs control Video vs control Problem-solving counselling vs video
Week 6 Week 12 Week 26 Week 52 Week 6 Week 12 Week 26 Week 52 Week 6 Week 12 Week 26 Week 52
Physical 
functioning
-2.98 (-6.94 to 0.97) -4.39 (-8.61 to -0.17)† -3.87 (-8.02 to 0.29) -2.42 (-7.10 to 2.27) -3.06 (-7.00 to 0.87) -2.19 (-6.39 to 2.02) -1.11 (-5.25 to 3.03) -1.13 (-5.77 to 3.52) 0.08 (-3.95 to 4.10) -2.21 (-6.48 to 2.07) -2.76 (-6.92 to 1.39) -1.29 (-5.94 to 3.36)
Role-physical -1.60 (-13.54 to 10.34) 2.08 (-9.17 to 13.33) -6.48 (-18.28 to 5.31) 4.16 (-9.06 to 17.37) 0.54 (-11.34 to 12.43) 9.80 (-1.41 to 21.01) -4.27 (-16.02 to 7.47) 3.70 (-9.41 to 16.81) -2.14 (-14.30 to 10.02) -7.72 (-19.12 to 3.69) -2.21 (-14.00 to 9.58) 0.46 (-12.66 to 13.57)
Bodily pain 0.09 (-7.22 to 7.41) -6.12 (-13.68 to 1.45) -3.81 (-11.47 to 3.85) -3.59 (-11.75 to 4.57) 2.04 (-5.24 to 9.32) 3.57 (-3.96 to 11.11) 2.15 (-5.48 to 9.78) 5.96 (-2.13 to 14.06) -1.95 (-9.39 to 5.50) -9.69 (-17.36 to -2.02)† -5.97 (-13.62 to 1.69) -9.56 (-17.66 to -1.46)†
General health 1.07 (-5.08 to 7.21) 1.31 (-5.15 to 7.77) 0.52 (-6.08 to 7.12) 0.73 (-5.92 to 7.38) 0.80 (-5.31 to 6.92) 4.38 (-2.06 to 10.81) 5.13 (-1.44 to 11.70) 2.45 (-4.15 to 9.05) 0.26 (-5.99 to 6.52) -3.06 (-9.61 to 3.49) -4.61 (-11.21 to 1.98) -1.72 (-8.32 to 4.88)
Vitality 5.11 (-0.97 to 11.19) 0.52 (-5.94 to 6.98) -1.92 (-8.49 to 4.65) 0.68 (-6.02 to 7.38) 5.39 (-0.67 to 11.44) 2.64 (-3.80 to 9.08) 3.35 (-3.19 to 9.90) 5.58 (-1.07 to 12.22) -0.27 (-6.47 to 5.92) -2.12 (-8.67 to 4.43) -5.27 (-11.84 to 1.30) -4.90 (-11.54 to 1.75)
Social functioning 0.83 (-6.31 to 7.97) -0.33 (-7.90 to 7.25) 1.02 (-6.50 to 8.54) -0.54 (-7.63 to 6.55) 1.15 (-5.96 to 8.26) 1.96 (-5.59 to 9.51) 5.86 (-1.63 to 13.35) 3.00 (-4.04 to 10.03) -0.32 (-7.59 to 6.96) -2.29 (-9.97 to 5.39) -4.84 (-12.36 to 2.67) -3.54 (-10.58 to 3.50)
Role-emotional 16.98 (5.63 to 28.34)‡ 14.07 (1.81 to 26.33)† 4.18 (-7.32 to 15.69) 6.97 (-5.61 to 19.55) 4.32 (-6.98 to 15.62) 8.68 (-3.54 to 20.90) 9.30 (-2.16 to 20.75) 11.28 (-1.21 to 23.76) 12.67 (1.11 to 24.23)‡ 5.39 (-7.04 to 17.83) -5.11 (-16.61 to 6.38) -4.31 (-16.79 to 8.18)




-2.43 (-5.14 to 0.28) -2.95 (-5.80 to -0.11)† -3.11 (-5.94 to -0.27)† -1.75 (-4.94 to 1.44) -0.79 (-3.49 to 1.90) 0.86 (-1.97 to 3.70) -0.84 (-3.66 to 1.99) 0.07 (-3.09 to 3.23) -1.64 (-4.39 to 1.12) -3.81 (-6.70 to -0.93)‡ -2.27 (-5.10 to 0.56) -1.82 (-4.98 to 1.35)
Mental component 
summary
4.69 (1.80 to 7.57)‡ 3.28 (0.22 to 6.33)† 2.32 (-0.91 to 5.55) 2.66 (-0.51 to 5.82) 2.01 (-0.86 to 4.88) 1.85 (-1.20 to 4.90) 3.75 (0.54 to 6.97)† 3.68 (0.54 to 6.83)† 2.67 (-0.26 to 5.61) 1.42 (-1.68 to 4.53) -1.43 (-4.66 to 1.79) -1.03 (-4.17 to 2.11)
Anxiety score -1.73 (-2.52 to -0.95)§ -1.89 (-2.72 to -1.07)§ -2.11 (-2.94 to -1.28)§ -1.68 (-2.58 to -0.78)§ -2.22 (-2.99 to -1.44)§ -2.23 (-3.04 to -1.42)§ -2.52 (-3.34 to -1.69)§ -2.34 (-3.24 to -1.44)§ 0.48 (-0.31 to 1.27) 0.34 (-0.49 to 1.16) 0.41 (-0.42 to 1.24) 0.66 (-0.23 to 1.55)
Depression score -2.06 (-3.23 to -0.89)§ -1.41 (-2.56 to -0.25)† -1.33 (-2.54 to -0.12)† -0.98 (-2.18 to 0.22) -1.56 (-2.71 to -0.40) -1.22(-2.37 to -0.08)† -1.22 (-2.42 to -0.01)† -0.91 (-2.10 to 0.29) -0.50 (-1.69 to 0.68) -0.18 (-1.34 to 0.98) -0.11 (-1.32 to 1.09) -0.08 (-1.27 to 1.11)
Table 3. Effect of interventions on changes in SF-36 and the Cantonese Hospital Anxiety and Depression Scale (HADS) from 
corresponding baseline scores by groups*
* Multivariate regression after controlling for age, total no. of chronic diseases, gender, education, marital status, social class by occupation, and the presence of 
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and 150 to receive the video (placebo) intervention. One 
hundred and fifty subjects who were screened negative, were 
allocated to the negative control group. Screened-positive 
subjects had a higher proportion of persons with more than 
two chronic diseases and worse SF-36 HRQOL scores 
than screened-negative subjects. There was no difference 
between the PSC and video (placebo) groups except for a 
higher mean HADS depression score in the former. One 
hundred and thirty-two (89%) subjects in the PSC group 
attended at least one of their respective sessions, as did 132 
(88%) of the video (placebo) group. A total of 69% subjects 
of the PSC group, 71% of those in the video group, and 
74% of the screened-negative controls completed the study 
at 52 weeks.
 Table 1 shows the changes in SF-36 scores from baseline 
to follow-up assessments at 6, 12, 26, and 52 weeks by 
groups, with missing data excluded from the analysis. 
There were significant improvements in the SF-36 mental 
component summary and role-emotional scores at week 6 in 
the PSC group, which were not found in the video (placebo) 
or screened-negative control groups. At subsequent follow-
up, there were no significant differences in the change 
in SF-36 scores, except for greater improvements in the 
Item Negative control Problem-solving counselling (PSC) Video (placebo)
Week 6 (n=137) Week 12 (n=131) Week 26 (n=127) Week 52 (n=112) Week 6 (n=114) Week 12 (n=113) Week 26 (n=114) Week 52 (n=103) Week 6 (n=117) Week 12 (n=117) Week 26 (n=119) Week 52 (n=106)
Physical functioning 2.5 (14.7)* 2.5 (14.1)* -0.2 (14.7) -0.8 (16.3) -0.3 (17.1) -1.7 (18.9) -3.5 (16.4)* -3.5 (16.7)* 0.5 (14.7) 1.0 (14.9) -0.8 (15.6) -1.9 (16.7)
Role-physical 4.6 (43.5) 2.3 (43.4)‡ 4.1 (41.2) 2.2 (45.0) 7.5 (51.1) 7.2 (45.0) -0.2 (47.0) 4.9 (43.9) 11.2 (47.3)* 16.1 (42.8)*‡ 4.8 (47.8) 5.6 (49.2)
Bodily pain 2.8 (27.9) 4.6 (24.8)* 2.8 (26.6) 0.1 (28.0) 3.6 (28.0) -0.1 (31.0)§ 0.7 (31.7) -4.1 (30.9)§ 7.1 (31.8)* 10.6 (32.5)*§ 7.5 (31.8)* 8.2 (30.5)* §
General health 4.6 (19.1)* 3.0 (18.6) 0.5 (21.0) 0.1 (20.4) 6.0 (25.7)* 5.1 (27.1)* 2.2 (26.3) 2.8 (26.7) 5.9 (26.2)* 9.0 (26.8)* 7.4 (27.6)* 4.6 (25.8)
Vitality -2.0 (20.9) -3.1 (21.2) -6.3 (22.2)* -5.5 (21.9)* 3.9 (24.7) -0.9 (27.8) -5.1 (27.8) -3.8 (26.0) 3.2 (25.0) -0.2 (24.5) -1.1 (24.8) 0.5 (23.0)
Social functioning 3.4 (20.2) 1.9 (20.5) 0.0 (24.9) -1.7 (22.8) 4.1 (33.1) 3.3 (35.6) 2.4 (30.4) -5.0 (29.4) 6.0 (30.7)* 5.9 (31.4)* 7.1 (33.0)* -0.6 (26.0)
Role-emotional -1.9 (30.7)† -3.1 (34.5) -4.5 (34.0)‡ -2.1 (31.7) 14.9 (51.5)*† 11.4 (55.9)* 2.3 (51.3) 1.3 (52.6) 4.5 (51.0) 9.9 (50.1)* 10.1 (47.1)*‡ 9.3 (46.4)*
Mental health -1.2 (13.5) -2.5 (13.8)* -5.0 (13.8)* -5.4 (14.8)* 3.1 (19.6) 0.8 (20.3) -0.9 (23.6) -1.2 (19.5) 0.0 (19.7) 0.3 (22.5) -0.3 (21.8) -1.0 (19.9)
Physical component summary 2.6 (9.6)* 2.5 (8.7)* 1.7 (9.0)* 0.8 (11.1) 0.9 (12.2) 0.3 (13.0)§ -0.6 (11.5) -0.7 (10.9) 2.8 (10.5)* 4.3 (10.7)*§ 1.8 (12.0) 1.3 (12.0)
Mental component summary -1.0 (7.2)† -1.9 (8.4)*† -2.7 (8.8)*‡ -2.8 (8.9)* 3.5 (12.7)*† 1.9 (13.2)† 0.0 (13.9) -0.6 (12.5) 1.0 (13.1) 0.5 (12.9) 1.4 (13.4)‡ 0.4 (12.0)
Table 1. Mean (SD) changes from baseline SF-36 scores by groups
* Significant change in SF-36 scores from baseline by paired t test, P<0.05
† Significant difference in score change between PSC and negative control groups by ANOVA, P<0.05
‡ Significant difference in score change between video and negative control groups by ANOVA, P<0.05
§ Significant difference in score change between PSC and video groups by ANOVA, P<0.05
Score Negative control Problem-solving counselling (PSC) Video (placebo)
Week 6 (n=137) Week 12 (n=131) Week 26 (n=127) Week 52 (n=112) Week 6 (n=114) Week 12 (n=113) Week 26 (n=114) Week 52 (n=103) Week 6 (n=117) Week 12 (n=117) Week 26 (n=119) Week 52 (n=106)
Anxiety score 0.6 (1.8)*†‡ 0.6 (1.7)*†‡  0.6 (1.8)*†‡ 0.5 (1.7)*†‡ -1.3 (3.8)*† -1.4 (4.2)*† -1.7 (4.2)*† -1.1 (4.1)*† -1.7 (3.2)*‡ -1.7 (3.2)*‡ -2.0 (3.2)*‡ -1.8 (3.5)*‡
Depression score 2.5 (4.2)*† 2.3 (3.8)*† 2.1 (3.7)*† 2.2 (3.4)* 0.5 (4.5)† 0.8 (4.7)† 0.9 (4.9)† 1.5 (4.8)* 1.0 (4.7)* 1.0 (4.7)* 1.1 (5.1)* 1.6 (4.9)*
Table 2. Mean (SD) changes in the Cantonese Hospital Anxiety and Depression Scale (HADS) scores from baseline by groups
* Significant change in HADS scores from baseline within the same group by parried t tests; P<0.05
† Significant difference in change in HADS score between PSC and negative control groups by ANOVA; P<0.05
‡ Significant difference in change in HADS score between video and negative control groups by ANOVA; P<0.05
Item Problem-solving counselling vs control Video vs control Problem-solving counselling vs video
Week 6 Week 12 Week 26 Week 52 Week 6 Week 12 Week 26 Week 52 Week 6 Week 12 Week 26 Week 52
Physical 
functioning
-2.98 (-6.94 to 0.97) -4.39 (-8.61 to -0.17)† -3.87 (-8.02 to 0.29) -2.42 (-7.10 to 2.27) -3.06 (-7.00 to 0.87) -2.19 (-6.39 to 2.02) -1.11 (-5.25 to 3.03) -1.13 (-5.77 to 3.52) 0.08 (-3.95 to 4.10) -2.21 (-6.48 to 2.07) -2.76 (-6.92 to 1.39) -1.29 (-5.94 to 3.36)
Role-physical -1.60 (-13.54 to 10.34) 2.08 (-9.17 to 13.33) -6.48 (-18.28 to 5.31) 4.16 (-9.06 to 17.37) 0.54 (-11.34 to 12.43) 9.80 (-1.41 to 21.01) -4.27 (-16.02 to 7.47) 3.70 (-9.41 to 16.81) -2.14 (-14.30 to 10.02) -7.72 (-19.12 to 3.69) -2.21 (-14.00 to 9.58) 0.46 (-12.66 to 13.57)
Bodily pain 0.09 (-7.22 to 7.41) -6.12 (-13.68 to 1.45) -3.81 (-11.47 to 3.85) -3.59 (-11.75 to 4.57) 2.04 (-5.24 to 9.32) 3.57 (-3.96 to 11.11) 2.15 (-5.48 to 9.78) 5.96 (-2.13 to 14.06) -1.95 (-9.39 to 5.50) -9.69 (-17.36 to -2.02)† -5.97 (-13.62 to 1.69) -9.56 (-17.66 to -1.46)†
General health 1.07 (-5.08 to 7.21) 1.31 (-5.15 to 7.77) 0.52 (-6.08 to 7.12) 0.73 (-5.92 to 7.38) 0.80 (-5.31 to 6.92) 4.38 (-2.06 to 10.81) 5.13 (-1.44 to 11.70) 2.45 (-4.15 to 9.05) 0.26 (-5.99 to 6.52) -3.06 (-9.61 to 3.49) -4.61 (-11.21 to 1.98) -1.72 (-8.32 to 4.88)
Vitality 5.11 (-0.97 to 11.19) 0.52 (-5.94 to 6.98) -1.92 (-8.49 to 4.65) 0.68 (-6.02 to 7.38) 5.39 (-0.67 to 11.44) 2.64 (-3.80 to 9.08) 3.35 (-3.19 to 9.90) 5.58 (-1.07 to 12.22) -0.27 (-6.47 to 5.92) -2.12 (-8.67 to 4.43) -5.27 (-11.84 to 1.30) -4.90 (-11.54 to 1.75)
Social functioning 0.83 (-6.31 to 7.97) -0.33 (-7.90 to 7.25) 1.02 (-6.50 to 8.54) -0.54 (-7.63 to 6.55) 1.15 (-5.96 to 8.26) 1.96 (-5.59 to 9.51) 5.86 (-1.63 to 13.35) 3.00 (-4.04 to 10.03) -0.32 (-7.59 to 6.96) -2.29 (-9.97 to 5.39) -4.84 (-12.36 to 2.67) -3.54 (-10.58 to 3.50)
Role-emotional 16.98 (5.63 to 28.34)‡ 14.07 (1.81 to 26.33)† 4.18 (-7.32 to 15.69) 6.97 (-5.61 to 19.55) 4.32 (-6.98 to 15.62) 8.68 (-3.54 to 20.90) 9.30 (-2.16 to 20.75) 11.28 (-1.21 to 23.76) 12.67 (1.11 to 24.23)‡ 5.39 (-7.04 to 17.83) -5.11 (-16.61 to 6.38) -4.31 (-16.79 to 8.18)




-2.43 (-5.14 to 0.28) -2.95 (-5.80 to -0.11)† -3.11 (-5.94 to -0.27)† -1.75 (-4.94 to 1.44) -0.79 (-3.49 to 1.90) 0.86 (-1.97 to 3.70) -0.84 (-3.66 to 1.99) 0.07 (-3.09 to 3.23) -1.64 (-4.39 to 1.12) -3.81 (-6.70 to -0.93)‡ -2.27 (-5.10 to 0.56) -1.82 (-4.98 to 1.35)
Mental component 
summary
4.69 (1.80 to 7.57)‡ 3.28 (0.22 to 6.33)† 2.32 (-0.91 to 5.55) 2.66 (-0.51 to 5.82) 2.01 (-0.86 to 4.88) 1.85 (-1.20 to 4.90) 3.75 (0.54 to 6.97)† 3.68 (0.54 to 6.83)† 2.67 (-0.26 to 5.61) 1.42 (-1.68 to 4.53) -1.43 (-4.66 to 1.79) -1.03 (-4.17 to 2.11)
Anxiety score -1.73 (-2.52 to -0.95)§ -1.89 (-2.72 to -1.07)§ -2.11 (-2.94 to -1.28)§ -1.68 (-2.58 to -0.78)§ -2.22 (-2.99 to -1.44)§ -2.23 (-3.04 to -1.42)§ -2.52 (-3.34 to -1.69)§ -2.34 (-3.24 to -1.44)§ 0.48 (-0.31 to 1.27) 0.34 (-0.49 to 1.16) 0.41 (-0.42 to 1.24) 0.66 (-0.23 to 1.55)
Depression score -2.06 (-3.23 to -0.89)§ -1.41 (-2.56 to -0.25)† -1.33 (-2.54 to -0.12)† -0.98 (-2.18 to 0.22) -1.56 (-2.71 to -0.40) -1.22(-2.37 to -0.08)† -1.22 (-2.42 to -0.01)† -0.91 (-2.10 to 0.29) -0.50 (-1.69 to 0.68) -0.18 (-1.34 to 0.98) -0.11 (-1.32 to 1.09) -0.08 (-1.27 to 1.11)
Table 3. Effect of interventions on changes in SF-36 and the Cantonese Hospital Anxiety and Depression Scale (HADS) from 
corresponding baseline scores by groups*
* Multivariate regression after controlling for age, total no. of chronic diseases, gender, education, marital status, social class by occupation, and the presence of 





34      Hong Kong Med J Vol 14 No 3 Supplement 3 June 2008
bodily pain score at 12 and 52 weeks, and in the physical 
component summary score at 12 weeks in the video group.
 Table 2 shows the change in HADS scores by groups, 
with missing data excluded from analysis. The anxiety 
scores at 6, 12, 26 and 52 weeks were significantly lower 
(improved) compared to baseline in both PSC and video 
groups, but were higher (worse) in the negative control 
group. There was no significant change in the depression 
score with time in the PSC group except for a higher score 
at 52 weeks, but the depression scores were significantly 
higher in the video (placebo) and negative control groups at 
all follow-up assessments.
 There was no significant change in the monthly 
consultation rates with time in all groups, whether the 
missing data were excluded or replaced by the last available 
values in the analyses.
 Table 3 shows the results of multivariate linear 
regressions of the changes in SF-36 and HADS scores 
following different interventions. Problem-solving 
counselling significantly improved the role-emotional 
score at week 6 more than the video (placebo), but was 
significantly less effective in improving general health and 
physical component summary scores at 12 weeks and the 
bodily pain score at 52 weeks.
 Mixed effects analysis for HADS scores, SF-36 scores, 
and consultation rates showed that changes in some SF-36 
(bodily pain, social functioning, and physical component 
summary) and HADS anxiety scores were associated with 
the intervention effects, with the video group improving 
more than the PSC group. Mixed proportional odds analysis 
was used for the SF-36 role-emotional score that took on 
four different values (0/33.3/66.7/100). The group by week 
interaction was significant and the effect of PSC appeared 
to decline over time (P=0.01). The video and PSC groups 
yielded no significant difference at weeks 6 and 12 but the 
video group improved more (starting from week 26).
 A random sample of the PSC sessions of 18 subjects 
was reviewed by the clinical psychologist. Each of the 
three tasks was achieved in over 80% of the sessions and a 
positive impact on the patient was noted in over 90% of the 
sessions.
 Post-intervention evaluation by the elderly showed that 
73% of them wished their family doctors could provide PSC; 
38% and 49% thought PSC and video-viewing respectively, 
improved their psychological health. Significantly more 
subjects in the video group (51%) than in the PSC group (33%) 
thought the intervention improved their general health.
Discussion
Unrecognised psychological problems were common 
among Chinese elderly patients attending primary care 
and appeared to impair quality of life as much as clinically 
diagnosed psychiatric diseases.5 Their psychological 
problems were unrecognised, despite their more frequent 
consultations, which implies that doctors seemed to have 
missed the opportunity to detect them. Opportunistic 
screening of psychological problems in elderly patients 
in primary care should be considered, so that appropriate 
treatment can be given early.
 Brief PSC by a trained primary care doctor had a short-
term (6- and 12-week) benefit on the quality of life of elderly 
patients who were screened positive for psychological 
problems, although it was not more effective than placebo 
(video-viewing) in the long term. The depression score 
did not increase in the PSC group, and in both the video 
and negative control groups until week 52, suggesting that 
PSC might have slowed the deterioration of depressive 
symptoms.
 Problem-solving counselling did not seem to be as 
effective in our patients as reported in another study,1 
probably because our subjects were older and had milder 
problems. The effect might be more sustainable if PSC 
could be reinforced and continued by the patients’ own 
primary care doctors.
 Other treatment methods for screened-positive 
psychological problems should be explored. Viewing of 
health education videos in groups unexpectedly improved 
quality of life compared with no intervention. The 
effectiveness of simple group activities in the treatment of 
screened-positive psychological problems deserves further 
studies.
 This study showed that primary care doctors could 
acquire the skills of PSC after a short course of training. 
Similar courses can be incorporated into vocational and 
continuing medical education programmes for primary care 
doctors, so that the large number of elderly patients with 
psychological problems can be managed in primary care.
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